EPISODE · May 6, 2020 · 7 MIN
Case Based Panel Discussion 2.7 Clinical Significance of HER2 Mutation How Does a Positive HER2 Mutation Effect Treatment Decisions in NSCLC
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.The doctors discuss a series of cases related to a diagnosis of NSCLC. In this video, the discussion is regarding a patient with a HER2 mutation, what is the clinical significance, and how does a positive HER2 mutation effect treatment decisions?
Embed this episode
NOW PLAYING
Case Based Panel Discussion 2.7 Clinical Significance of HER2 Mutation How Does a Positive HER2 Mutation Effect Treatment Decisions in NSCLC
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.